by Stacey Johnson | May 24, 2012
My grandfather was a mathematician and chemical engineer who worked on the Manhattan Project. I dated a chemical engineer for two years. Those two associations are the full breadth of my understanding of this field of science. Apparently I took chemistry in high...
by Stem Cell Network | May 16, 2012
Welcome to Signals Blog, the new home and new name for the Stem Cell Network Blog. Why the change? After nearly four years, 207 blog posts and several “best of” awards, the SCN Blog finally outgrew its dish, so to speak. Late last year, we began planning...
by Paul Krzyzanowski | May 16, 2012
Commercialization plenary summary: part 4 of 4 The last speaker of the commercialization plenary at the Till and McCulloch Meetings earlier this month was Dr. Stephen Minger from GE Healthcare, who shared GE’s perspective regarding the therapeutic and research...
by Paul Krzyzanowski | May 1, 2012
Commercialization plenary summary, part 1 of 4 Till and McCulloch Meeting (#TMM2012) attendees in Montreal had the opportunity to hear from four speakers involved in commercializing discoveries in regenerative medicine, from the perspectives of not-for-profit,...
Comments